Providing support to drug users infected with hepatitis C: The role of methadone maintenance treatment staff

Journal of Maintenance in the Addictions

Volumn 3, Issue 1, 2006, Pages 33-46

  Astone, Janetta M ^a   Strauss, Shiela M ^a   Munoz Plaza, Corrine ^a   Hagan, Holly ^a   Des Jarlais, Don C ^b  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Hepatitis C; Methadone maintenance treatment program; Treatment staff

Indexed keywords

EID: 33746642522     PISSN: 10911332     EISSN: 15407624     Source Type: Journal    
DOI: 10.1300/J126v03n01_04     Document Type: Article

References (41)

1. Alter, M.J. (2002). Prevention of spread of hepatitis C. Hepatology, 36(5 Suppl 1), S93-S98.
2. Astone, J., Strauss, S. M., Vassilev, Z.P., Des Jarlais, D.C. (2003). Provision of hepatitis C education in a nationwide sample of drug treatment programs. Journal of Drug Education, 33(1), 107-117.
3. Backmund, M., Meyer, K., Von Zielonka, M., Eichenlaub, D. (2001). Treatment of hepatitis C infection in injection drug users. Hepatology, 34, 188-193.
4. Bae, J.P. (1997). Assessing the need, use, and developments in mental health/substance abuse care. Health Care Financing Review, 18, 1-4.
5. Bayer, A.M. (2003). The ABCs of hepatitis and HIV. Training presented at the National Development and Research Institutes, New York, NY, January 16, 2003.
6. Chitwood, D.D., McBride, D.C., French, M.T., Comerford, M. (1999). Health care need and utilization: A preliminary comparison of injection drug users, other illicit drug users, and nonusers. Substance Use and Misuse, 34, 727-746.
7. Contoreggi, C., Rexroad, V.E., Lange, W.R. (1998). Current management of infectious complications in the injecting drug user. Journal of Substance Abuse Treatment, 15, 95-106.
8. Crofts, N., Louie, R., Loff, B. (1997). The next plague: Stigmatization and discrimination related to hepatitis C virus infection in Australia. Health and Human Rights, 2(2), 86-97.
9. Dalgard, O., Bjoro, K., Hellum, K., Myrvang, B., Skaug, K., Gutigard, B., Bell, H. (2002). Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. European Addiction Research, 8, 45-49.
10. Dhopesh, V.P., Taylor, K.R., Burke, W.M. (2000). Survey of hepatitis B and C in an addiction treatment unit. American Journal of Drug and Alcohol Abuse, 26(4), 703-707.
11. Edlin, B.R. (2002). Prevention and treatment of hepatitis C in injection drug users. Hepatology, 36(5 Suppl 1), S210-S219.
12. Ennis, E. (2002). Response: applying HIV strategies to hepatitis prevention. Science & Practice Perspectives, 1, 11-12.
13. Fukunishi, T., Hosaka, T., Negishi, M., Moriya, H., Hayashi, M., Matsumoto, T. (1998). Avoidance coping behavior and low social support are related to depressive symptoms in HIV-positive patients in Japan. Psychosomatics, 39(1), 82-83.
14. Hagan, H., Thiede, H., Weiss, H.S., Hopkins, S.G., Duchin, J.S., Alexander, E.R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42-46.
15. Heimer, R., Clair, S., Grau, L.E., Bluthenthal, R.N., Marshall, P.A., Singer, M. (2002). Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction, 97(10), 1277-1287.
16. Koch, M., Banys, P. (2001). Liver transplantation and opioid dependence. Journal of the American Medical Association, 285,1056-1058.
17. McCarthy, J.J., Flynn, N. (2001). Hepatitis C in methadone maintenance patients: Prevalence and public policy implications. Journal of Addictive Diseases, 20, 19-31.
18. McCoy, H.V., Messiah, S.E., Zhao, W. (2002). Improving access to primary health care for chronic drug abusers: An innovative systematic intervention for providers. The Journal of Behavioral Health Services and Research, 29, 445-457.
19. Morrison, D.S., Gilchrist, G., Ahmed, S. (2002). Potential of specialist drug services to deliver hepatitis B vaccination. Communicable Diseases and Public Health, 5(4), 321-323.
20. National Institutes of Health (2002). Management of hepatitis C: 2002. Available at http://consensus.nih.gov
21. NIDA Community Bulletin Report-Hepatitis Available at http://166.112.78.61/HepatitisAlert/HepatitisAlert.html.
22. Nyamathi, A., Leake, B., Keenan, C., Gelber, L. (2000). Type of social support among homeless women: Its impact on psychosocial resource, health and health behaviors, and use of health services. Nursing Research, 49 (6), 318-326.
23. O'Dell, K.J., Turner, N.H., Weaver, G.D. (1998). Women in recovery from drug misuse: An exploratory study of their social networks and social support. Substance Use and Misuse, 33 (8), 1721-1734.
24. Penninx, B.W., Van Tilburg, T., Deeg, D.J., Kriegsman, D.M., Boeke, A.J., Van Eijk, J.T. (1997). Direct and buffer effects of social support and personal coping resources in individuals with arthritis. Social Science and Medicine, 44(3), 393-402.
25. Power, R., Koopman, C., Volk, J., Israelski, D.M., Stone, L., Chesney M.S., Spiegel, P. (2003). Social support, substance use and denial in relation to antiretroviral treatment adherence among HIV infected persons. AIDS Patient Care and STDs, 17(5), 245-252.
26. Pratt, C.-C.N.U., Paone, D., Carter, B.J., Layton, M.C. (2002). Hepatitis C screening and management practices: A survey of drug treatment and syringe exchange programs in New York City. American Journal of Public Health, 92, 1254-1256.
27. Sorensen, J.L., Masson, C.L., Perlman, D.C. (2002). HIV/hepatitis prevention in drug abuse treatment programs: Guidance from research. Science and Practice Perspectives, 1, 4-11.
28. Stein, M. D., Maksad, J., Clarke, J. (2001). Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence, 61, 211-215.
29. Strathdee, S.A., Palepu, A., Cornelisse, P.G., Yip, B., O'Shaugnessy, M.V., Montaver, J.S., Schechter, M.T., Hogg, R.S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547-549.
30. Strauss, S.M., Falkin, G. P., Vassilev, Z., Des Jarlais, D.C., Astone, J. (2002). A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment, 22(2), 55-62.
31. Strauss, S., Astone, J., Des Jarlais, D., Hagan, H. (2004). A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug and Alcohol Dependence, 73, 227-236.
32. Sylvestre, D.L. (2002). Treating hepatitis C in methadone maintenance patients: An interim analysis. Drug and Alcohol Dependence, 67, 117-123.
33. Teitelbaum, M., Walker, A., Gabay, M., Gross, M., Mason, T., Weitzman, E. (1992). Analysis of barriers to the delivery of integrated primary care services and substance abuse treatment : Case studies of nine linkage program projects. Washington, DC: Health Resources and Services Administration and ABT Associates, Inc.
34. Tucker, J.S., Orlando, M., Burnam, M.A., Sherbourne, C.D., Kung, F.Y., Gifford, A.L. (2004). Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23 (4) 363-370.
35. Umbricht-Schneiter, A., Ginn, D.H., Pabst, K.M., Bigelow, E. (1994). Providing medical care to methadone clinic patients: Referral vs. on-site care. American Journal of Public Health, 84, 207-210.
36. Walley, A.Y., White, M., Song, Y., Kushell, M., Tulsky, J.P. (2003). Women methadone clients are less knowledgeable about hepatitis C treatment. Poster presented at the sixty-fifth annual scientific meeting of the College of Problems on Drug Dependence, Bal Harbour, FL, June 16, 2003.
37. Williams, I. (1999). Epidemiology of hepatitis C in the United States. American Journal of Medicine, 107, 2S-9S.
38. Winstock, A. R., Sheridan, J., Lovell, S., Farrell, M., Strang, J. (2000). National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. European Journal of Clinical Microbiology and Infectious Diseases 19, 823-828.
39. Zickmund, S., Hillis, S., Barnett, M., Ippolito, L., LaBrecque, D. (2004). Hepatitis C virus-infected patients report communication problems with physicians. Hepatology, 39, 999-1007.
40. Zweben, J.E. (2002). Emotional and psychiatric barriers to addressing HCV. Paper presented at American Methadone Treatment Association Conference, Foster City, CA, March.
41. Zweben, J.E. (2001). Hepatitis C: Education and counseling issues. Journal of Addictive Diseases, 20(1), 33-42.